News by topic

Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

Hepatitis C treatment news

Show

From To
Hepatitis C treatment
Roche’s Pegasys receives EU approval for the treatment of chronic hepatitis C in children five years of age and older

Roche announced today that the European Medicines Agency (EMA) has expanded the approval of Pegasys (peginterferon alfa-2a) plus ribavirin for the treatment of chronic hepatitis C virus (HCV). The new label includes children and adolescents five years of age and older, who have not received treatment and who have tested positive for the virus.

Published
19 March 2013
From
Roche press release
Hepatitis C treatment
Telaprevir shows promise in black patients with genotype 1 HCV

Preliminary data presented here at the 2013 Conference on Retroviruses and Opportunistic Infections show that combination telaprevir treatment may be effective in black null responder patients with chronic genotype 1 hepatitis C.

Published
12 March 2013
From
Healio
Hepatitis C treatment
French studies report real-world data on use of telaprevir and boceprevir in people with HIV and hepatitis C co-infection

Adding boceprevir or telaprevir to interferon-based therapy showed promising indications of efficacy and acceptable safety for difficult-to-treat HIV/HCV co-infected prior non-responders in a pair of French studies presented

Published
05 March 2013
By
Liz Highleyman
Hepatitis C treatment
Patient Dilemma: Treat Hepatitis C Now or Hold Out?

Being diagnosed with a potentially fatal disease usually triggers immediate treatment. But a growing number of people infected with hepatitis C are putting off therapy, choosing instead to roll the dice and wait for a new generation of drugs to become available.

Published
05 March 2013
From
Wall Street Journal
New and experimental hepatitis C treatment
Sofosbuvir/ledipasvir/ribavirin cures 100% of genotype 1 hepatitis C patients

An interferon-free regimen containing sofosbuvir (formerly GS-7997), ledipasvir (formerly GS-5885) and ribavirin produced a 12-week post-treatment sustained virological response (SVR12) rate of 100% for both treatment-naive hepatitis C

Published
05 March 2013
By
Liz Highleyman
Hepatitis C treatment
Milk Thistle Drug May Help Control HCV Replication after Liver Transplant

Silibinin, a medication derived from the milk thistle plant, lowered hepatitis C virus (HCV) levels in patients awaiting liver transplantation in a pilot study, which may help reduce the risk of HCV recurrence in the new liver, Spanish researchers reported in the March 2013 Journal of Hepatology.

Published
02 March 2013
From
HIVandhepatitis.com
Hepatitis C treatment side-effects
Health Canada Warns Of Serious Skin Reactions From Hepatitis C Drug

Two months after the FDA issued a safety alert informing about the serious skin reactions, some fatal, in patients taking Vertex Pharmaceuticals Inc.'s (VRTX: Quote) hepatitis C drug Incivek (telaprevir), it is now health Canada's turn to alert health-care providers and patients.

Published
01 March 2013
From
RTT News
Hepatitis C treatment
Pakistan: Low cost Hepatitis C treatment: ‘Everything is heading in the right direction – on paper’

The production of a local biosimilar version of interferon alfa is being delayed by bureaucratic obstacles, according to its developer.

Published
28 February 2013
From
Express Tribune
Hepatitis C treatment
Pakistan: Hepatitis C patients get the axe as hospitals stop treatment

ISLAMABAD: Most public hospitals in twin cities have stopped providing treatment to Hepatitis patients who cannot afford to pay, putting their lives at stake.

Published
28 February 2013
From
The Express Tribune
Hepatitis C treatment
Study shows value of hepatitis C therapy for HIV co-infected patients with compensated cirrhosis

Spanish research published in the online edition of Clinical Infectious Diseases shows the benefits of successful hepatitis C therapy for people co-infected with HIV who have compensated liver

Published
28 February 2013
By
Michael Carter
← First12345...22Next →

Filter by country